Contract Development and Manufacturing Organization Market worth USD 278.98 Billion by 2026; Increasing Demand for Pharmaceutical Products Will Aid…

Key Companies Covered in the CDMO Market Research Report are Catalent, Inc, Baxter, Vetter, Recipharm AB, Albany Molecular Research Inc. (AMRI), Thermo Fisher Scientific Inc. (Patheon), Unither, DPT LABORATORIES LTD., NextPharma Technologies and other key market players.

Pune, March 24, 2020 (GLOBE NEWSWIRE) -- The global contract development and manufacturing organization market size is projected to reach USD 278.98 billion by the end of 2026. Mergers and acquisitions are a growing trend among major companies across the world. According to a report published by Fortune Business Insights, titled Contract Development and Manufacturing Organization (CDMO) Market Size, Share & Industry Analysis, By Service {By CMO (API, Finished Product {Solid Dosage Forms, Injectables, and Others}, and Packaging)} {By CRO (Discovery, Preclinical, Clinical Trial, and Laboratory Services)} and Regional Forecast, 2019-2026, the market was worth USD 130.80 billion in 2018 and will exhibit a CAGR of 10.0% during the forecast period, 2019-2026.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/contract-development-and-manufacturing-organization-cdmo-outsourcing-market-102502

Report Overview:

The contract development and manufacturing organization market is segmented on the basis of factors such as service and geographies. The report provides forecast values for the market for the period of 2019-2026. The factual figures have been obtained through trusted sources. Moreover, these predictions are made on the basis of extensive research analysis methods, coupled with the opinions of experienced market research professionals. The report highlights the latest product launches and labels major innovations in the market. In addition to this, it states the impact of these products on the growth of the market. The competitive landscape has been discussed in detail and predictions are made with respect to leading companies and products in the coming years.

Story continues

Product Overview:

A contract development and manufacturing organization (CDMO) helps healthcare companies for the development of drugs. It is involved in the overall process, right from the clinical trials till the commercialization and distribution of the drugs. The complexities in therapies and lack of in-house manufacturing capabilities will have a positive impact on the growth of the market in the coming years. The high investment in CDMOs will bode well for the overall market in the coming years. Moreover, the increasing number of strategic mergers and collaborations will contribute to the growth of the market. The use of advanced technologies in drug development processes will emerge in favor of the companies operating in the market.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/contract-development-and-manufacturing-organization-cdmo-outsourcing-market-102502

Recipharm AB Introduces New Fully Integrated Service Platform

Accounting to the huge potential held by CDMOs, several companies are looking to invest more in the development of newer products. The huge investments have yielded a few exceptional products in recent years. In May 2019, Recipharm AB announced the launch of a fully integrated service platform for inhalation products. This will include the early stages of the products including the pre-clinical trials to the commercialization of the products. Recipharms latest product will generate huge sales and subsequently high revenues for the company. This will not just benefit the company, but will have a positive impact on the growth of the overall market in the coming years.

Asia Pacific to Register Highest CAGR; Increasing Company Collaborations Will Aid Growth of the Regional Market

The report analyses the ongoing CDMO market trends across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Among these regions, the market in Asia Pacific will register the highest CAGR in the coming years driven by the increasing number of company collaborations and mergers in several countries across the world. The market in North America is projected to emerge dominant in the coming years, owing to the presence of several well-established companies. As of 2018, the market in North America was worth USD 48.72 billion in 2018 and this value is projected to increase further in the coming years.

List of key companies profiled in theCDMO Market Research Report are report:

Industry Developments:

February 2019: Jubilant Biosys collaborated with Sanofi to develop small molecule inhibitors for in the CNS therapeutic area.

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/contract-development-and-manufacturing-organization-cdmo-outsourcing-market-102502

Detailed Table of Content:

1. Introduction 1.1. Research Scope 1.2. Market Segmentation 1.3. Research Methodology 1.4. Definitions and Assumptions 2. Executive Summary 3. Market Dynamics 3.1. Market Trends 3.2. Market Drivers 3.3. Market Restraints 3.4. Market Opportunities 4. Key Insights 4.1. Key Industry Developments (Mergers, Acquisitions, & Partnerships,) 4.2. The Regulatory Scenario for key countries/Regions 4.3. Key Market Trends 4.4. Key Services Mapping by Leading Players 5. Global Contract Development and Manufacturing Organization (CDMO) Market Analysis, Insights and Forecast, 2015-2026 5.1. Key Findings / Summary 5.2. Market Analysis, Insights and Forecast By Service 5.2.1. CMO 5.2.1.1. API Manufacturing 5.2.1.2. Finished Product Manufacturing 5.2.1.2.1. Solid Dosage Forms 5.2.1.2.2. Injectables 5.2.1.2.3. Others (Semisolids/liquids, Powder) 5.2.1.3. Packaging 5.2.2. CRO 5.2.2.1. Discovery 5.2.2.2. Preclinical 5.2.2.3. Clinical 5.2.2.4. Laboratory Services 5.3. Market Analysis, Insights and Forecast By Region 5.3.1. North America 5.3.2. Europe 5.3.3. Asia Pacific 5.3.4. Rest of the World

TOC Continued.!

Request for Customization: https://www.fortunebusinessinsights.com/enquiry/customization/contract-development-and-manufacturing-organization-cdmo-outsourcing-market-102502

Have a Look at Related Reports:

Contract Research Organization (CRO) Services Market Size, Share and Global Trend By Service Type (Discovery, Pre-Clinical, Clinical, Laboratory Services), By Application (Oncology, Cardiology, Infectious Disease, Metabolic Disorders), By End User(Pharmaceutical & Biotechnological Companies, Medical Device Companies, Academic & Research Institutes) and Geography Forecast till 2026

Clinical Laboratory Services Market Size, Share and Global Trend By Laboratory Type (Speciality Clinical Laboratory, Integrated Clinical Laboratory), By Ownership (Hospital owned clinical laboratory, Standalone clinical laboratory, Others), By End User (Hospitals, Clinics, Research Centers, Others), and Geography Forecast till 2026

Clinical Chemistry Market Size, Share and Global Trend By Product Type (Analyzers, Reagents & Consumables), By Application (General Chemistry Test, Liver Function Test, Kidney Function Test, Urinalysis, Electrolyte Panel, Lipid Profile, Specialty Chemical Test, Others), By End User (Hospitals, Diagnostic/Pathology Centers, Ambulatory Surgery Centers (ASC), Others), and Geography Forecast till 2026

Drug Discovery Informatics Market Size, Share & Industry Analysis, By Service Type (In-house, Outsourced), By Modality (Cloud-based Systems, In-campus Platform), By Application (Data Sequencing, Molecular Docking, Identification and Validation Informatics, Target Data Analysis, Others), By End User (Pharmaceutical Companies, Contract Research Organizations, Biotechnology Companies, Others) and Regional Forecast, 2019-2026

Biomarkers MarketSize, Share & Industry Analysis, By Indication (Oncology, Cardiology, Neurology, and Others), By End User (Pharmaceutical & Biotechnology Companies, Diagnostics & Research Laboratories, Hospitals & Specialty Clinics, and Others), and Regional Forecast, 2019-2026

Influenza Medication Market Size, Share & Industry Analysis, By Treatment (Baloxavir marboxil, Oseltamivir phosphate, Others), By Influenza Type (Influenza A, Influenza B), By Route of Administration (Oral, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026

Telemedicine MarketSize, Share & Industry Analysis By Type (Products, Services), By Application (Teleradiology, Telepathology, Teledermatology, Telepsychiatry, Telecardiology, Others), By Modality (Store-and-forward (Asynchronous), Real-time (Synchronous), Others), By End User (Healthcare Facilities, Homecare), and Regional Forecast 2019-2026

Telehealth Market Size, Share and Industry Analysis By Type (Products, Services), By Application (Telemedicine, Patient Monitoring, Continuous Medical Education, Others), By Modality (Store-and-forward (Asynchronous), Real-time (Synchronous), Remote Patient Monitoring), By End User (Healthcare Facilities, Homecare, Others), and Geography Forecast, 2019 - 2026

Injectable Drug Delivery MarketSize, Share and Industry Analysis By Device Type (Conventional Injectable, Pre-filled Syringes, Auto-injectors, Pen-injectors, Others), By Application (Autoimmune Disorders, Diabetes, Pain Management, Aesthetic Treatments, Others), By Route of Administration (Subcutaneous, Intravenous, Intramuscular, Others), By End-User (Hospitals, Home Care Settings, Clinics, Others), and Regional Forecast 2019-2026

Regenerative Medicine Market Size, Share and Industry Analysis By Product (Cell Therapy, Gene Therapy, Tissue Engineering, Platelet Rich Plasma), By Application (Orthopaedics, Wound Care, Oncology), By Distribution Channel (Hospitals, Clinics) & Regional Forecast, 2019 - 2026

Immunology Market Size, Share and Industry Analysis By Drug Class (Monoclonal antibody (mAb), Fusion Proteins, Immunosuppressant, Polyclonal antibody (pAb), Others), By Disease Indication (Rheumatoid Arthritis, Psoriatic Arthritis, Plaque Psoriasis, Ankylosing Spondylitis, Inflammatory Bowel Disease, Prophylaxis of Organ Rejection, Others), By Distribution Channel, and Regional Forecast 2019-2026

About Us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights Pvt. Ltd. 308, Supreme Headquarters, Survey No. 36, Baner, Pune-Bangalore Highway, Pune - 411045, Maharashtra, India. Phone:US :+1 424 253 0390 UK : +44 2071 939123 APAC : +91 744 740 1245 Email: sales@fortunebusinessinsights.com Fortune Business Insights LinkedIn | Twitter | Blogs

Press Release: https://www.fortunebusinessinsights.com/press-release/contract-development-and-manufacturing-organization-cdmo-market-9673

See original here:
Contract Development and Manufacturing Organization Market worth USD 278.98 Billion by 2026; Increasing Demand for Pharmaceutical Products Will Aid...